FDA — authorised 5 August 1996
- Marketing authorisation holder: PARKE DAVIS
- Status: approved
FDA authorised Cerebyx on 5 August 1996
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 5 August 1996.
PARKE DAVIS holds the US marketing authorisation.